No Data
Moderna Stock Hits 52-week Low at $23.71 Amid Market Challenges
CureVac Gets FDA Green Light for Lung Cancer Trial With MRNA-Based Immunotherapy
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
Moderna Options Spot-On: On April 4th, 144.56K Contracts Were Traded, With 826.61K Open Interest
Moderna (NasdaqGS:MRNA) Takes 17% Hit Amid Global Trade Concerns
RFK Jr. to Reinstate 20% of HHS Staff Laid off After DOGE Errors